Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04780607
Status:
UNKNOWN
Last Update Posted:
2021-03-03
First Post:
2021-03-01
Brief Title:
Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease
Sponsor:
Beijing Anzhen Hospital
Organization:
Beijing Anzhen Hospital
Study Overview
Official Title:
Multicenter Results of Mitral Valve Surgery in Patients With Rheumatic Heart Disease
Status:
UNKNOWN
Status Verified Date:
2021-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
rheumatic heart disease remains the majority valvular disease in low and middle income countries which mostly affected mitral valve surgical treatment is the most effective strategy to improve the outcomes of middle or late-stage RHD patient however whether mitral valve repair surgery is superior to replacement or other evolving interventional device remains controversial this study aims to investigate the results of repair surgery compared with replacement or other treatment strategy from international multicenters
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None